Correlia Biosystems

📍 Berkeley, United States👥 13 employees💰 Last funded Jul 2024
Biotechnology Research🌐 correliabio.com
Website LinkedIn
Correlia Biosystems develops innovative microscale tools that accelerate the rate of molecular interactions for rapid measurements of biomolecules. The customizable PIXI​ platform opens up new biological questions for interrogation from less than two microliters of sample, with rapid results that allow for dynamic monitoring of protein expression profiles.
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United States
2
Bahrain
1
United Kingdom
1
Investor activity2018–2024 · investors recorded per year
2018320241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Correlia Biosystems?
Correlia Biosystems has 4 investors on record on gritt.io.
When did Correlia Biosystems last raise funding?
The most recent investment in Correlia Biosystems recorded on gritt.io was in July 2024.
What industry is Correlia Biosystems in?
Correlia Biosystems operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Correlia Biosystems based?
Correlia Biosystems is headquartered in Berkeley, United States.